
CSPC Pharmaceutical Group Investor Relations Material
Latest events

H1 2025
22 Aug, 2025

Q1 2025
29 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CSPC Pharmaceutical Group Limited
Access all reports
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company operates through multiple segments, including finished drugs, bulk drug manufacturing, and innovative drug development. Its product portfolio spans a range of therapeutic areas such as cardiovascular, oncology, anti-infectives, and central nervous system disorders. The company is headquartered in Shijiazhuang, China, and its shares are listed on the HKEX.
Key slides for CSPC Pharmaceutical Group Limited


Q1 2025
CSPC Pharmaceutical Group Limited


H1 2025
CSPC Pharmaceutical Group Limited
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
1093
Country
🇭🇰 Hong Kong